The authors wish to make the following corrections to this paper [1]:
Figure 6 contains some errors, and should be replaced with the correct one. During the several rounds of figure assembly, the following mistakes were unintentionally made by the authors: the GSK3β band of Figure 6C and the β-tubulin band of Figure 6D are introduced from the same original β-tubulin band in Figure 5D. In addition, the Nrf2 band of Figure 4A was mistakenly selected, as it was the short exposure of the Nrf2 band in Figure 4B. The authors have provided correct versions of Figure 4A and Figure 6.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Figure 4. The effects of SHK are dependent upon the Nrf2 in L-02 cells. (A,B) L-02 cells were treated with SHK for the indicated durations, and then the protein levels were examined via Western blot analysis. (C–F) L-02 cells were treated with increasing concentrations of SHK for 1 h followed by 4 h APAP treatment, and then the mRNA expression of Nrf2, HO-1, GCLc and GCLm was detected by real-time polymerase chain reaction (PCR). (G–I) Cells were pretreated with brusatol (160 nM) for 2 h, followed by treatment with SHK for 1 h, and then the cells were exposed to APAP for 24 h. Cell viability, GSH and ROS level were assessed. All of the data shown represent the average from three independent experiments. * p < 0.05 versus the control group; ** p < 0.01 versus the control group; # p < 0.05 versus the APAP group; ^ p < 0.05 versus the SHK plus APAP group.
Figure 6. The effect of SHK on Akt-induced GSK3β phosphorylation and Nrf2 upregulation. (A,B) L-02 cells were incubated with SHK for the indicated durations, and then the levels of GSK3β phosphorylation were evaluated via Western blotting. (C) L-02 cells were pretreated with LY294002 (20 μM) for 1 h followed by treatment with SHK for 4 h, and GSK3β protein and phosphorylated GSK3β levels were evaluated via Western blotting. (D) L-02 cells were pretreated with lithium chloride (20 mM) for 4 h, followed by treatment with SHK for 4 h, and GSK3β protein and phosphorylated GSK3β levels were evaluated via Western blotting.
Reference
1. Li, H.; Chen, Y.; Zhang, J.; Chen, X.; Li, Z.; Liu, B.; Zhang, L. Shikonin Attenuates Acetaminophen-Induced Hepatotoxicity by Upregulation of Nrf2 through Akt/GSK3β Signaling. Molecules; 2019; 24, 110. [DOI: https://dx.doi.org/10.3390/molecules24010110] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30597971]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details

1 Department of Pharmacology, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China;
2 Guangzhou Key Laboratory of Construction and Application of New Drug Screening Model Systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of Ordinary Universities of Guangdong Province, Guangdong Pharmaceutical University, Guangzhou 510006, China
3 Guangzhou Key Laboratory of Construction and Application of New Drug Screening Model Systems, Guangdong Pharmaceutical University, Guangzhou 510006, China; Key Laboratory of New Drug Discovery and Evaluation of Ordinary Universities of Guangdong Province, Guangdong Pharmaceutical University, Guangzhou 510006, China; The Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou 510006, China